The FDA has qualified AI-Based Histologic Measurement of NASH, or AIM-NASH — the first AI drug development tool — to assist ...
Everyday Health on MSN
MASH: Is semaglutide right for you?
Learn about semaglutide’s effectiveness and clinical trial results and whether it could be right for you in your MASH treatment plan.
Mayo Clinic researchers have uncovered how aging "zombie cells" trigger harmful inflammation that accelerates a severe and ...
Everyday Health on MSN
Using GLP-1s for MASH: Dos and don’ts
If you have MASH, GLP-1 medications may help treat the condition. Set yourself up for success with expert advice on diet, exercise, dose scheduling, and more.
Panelists discuss how defining and tracking meaningful real-world outcomes ensures accountability and value in MASH ...
Mayo Clinic researchers have discovered how aging "zombie cells" contribute to inflammation that speeds up a serious form of ...
Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...
With David Beckham’s endorsement, old pie shops and posh hotel restaurants are seeing a surge in demand for minced beef, flaky crust and mashed potatoes.
An immaculate cast carries the composer’s fiendish score with panache in this first London production for almost a decade ...
The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with metabolic ...
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback